eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/ β-catenin in gastric cancer
ConclusionThese results suggest that eIF4EBP3 is a novel TSG methylated in gastric cancer that may play important roles in GC development and liver metastasis and indicate eIF4EBP3 as a potential metastasis and survival biomarker for GC.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
More News: Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | Genetics | Liver | Study | Urology & Nephrology